Risk-Reducing salpingo-oophorectomy in BRCA1/2 mutant carriers

Risk-Reducing salpingo-oophorectomy in BRCA1/2 mutant carriers - Risk-Reducing salpingo-oophorectomy in BRCA1/2 mutant carriers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027723

Enrollment

Registered

2017-09-01

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BRCA1/2 mutant carriers

Interventions

Risk-reducing salpingo-oophorectomy (RRSO)

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1)BRCA1/2 mutant carriers 2)prefer not to pregnant women 3)Performance Status: 0-1 4)informed consent

Exclusion criteria

Exclusion criteria: pregnant woman or possibility for pregnant women

Design outcomes

Primary

Measure	Time frame
The safety and efficacy of risk reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutnat carriers	—

Countries

Japan

Contacts

Public ContactTaisuke Mori

Kyoto Prefectural University of Medicine Department of Obstetrics and Gynecology

moriman@koto.kpu-m.ac.jp075-251-5560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026